# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA804101 | F | In vitro adenylate cyclase response in neuroblastoma cell line | Homo sapiens | 2 | ALA1135440 | cell-based format | Scientific Literature | |
2. | ALA804102 | F | In vitro adenylate cyclase response in neuroblastoma cell line SK-N-MC | Homo sapiens | 1 | ALA1135440 | cell-based format | Scientific Literature | |
3. | ALA883520 | F | In vivo antiproliferative activity against SK-N-MC cell line | Homo sapiens | 2 | ALA1149329 | organism-based format | Scientific Literature | |
4. | ALA804103 | F | Inhibition of forskolin-stimulatedcAMP accumulation in SK-N-MC cells reported as a rightward shift of the NPY dose-response curve at 10 uM concentration | Homo sapiens | 1 | ALA1129132 | cell-based format | Scientific Literature | |
5. | ALA804104 | F | Ability to reverse NPY-induced intracellular [Ca2+] mobilization in SK-N-MC cells | Homo sapiens | 1 | ALA1130228 | cell-based format | Scientific Literature | |
6. | ALA804105 | F | Percentage viability of compound against SK-N-MC cell line; 92-94% | Homo sapiens | 1 | ALA1148455 | cell-based format | Scientific Literature | |
7. | ALA804106 | F | Percentage viability of compound against SK-N-MC cell line; NE means No effect | Homo sapiens | 1 | ALA1148455 | cell-based format | Scientific Literature | |
8. | ALA804107 | F | In vitro inhibition of CGRP-mediated cAMP production in SK-N-MC cells | Homo sapiens | 10 | ALA1150009 | cell-based format | Scientific Literature | |
9. | ALA804108 | F | In vitro inhibition of CGRP-mediated cAMP production in SK-N-MC cells; not determined | Homo sapiens | 3 | ALA1150009 | cell-based format | Scientific Literature | |
10. | ALA804109 | F | Ability to antagonize 1 nM NPY''s inhibition of forskolin-stimulated cyclic AMP accumulation in SK-N-MC cells | Homo sapiens | 4 | ALA1131957 | cell-based format | Scientific Literature | |
11. | ALA804110 | F | In vitro functional activity determined by its ability to antagonize 1 nM NPYs inhibition of forskolin -stimulated cyclic AMP accumulation in SK-N-MC cells | Homo sapiens | 12 | ALA1131030 | cell-based format | Scientific Literature | |
12. | ALA804111 | F | Inhibition of NPY induced intracellular Ca++ mobilization in SK-N-MC cells is evaluated. | Homo sapiens | 1 | ALA1130762 | cell-based format | Scientific Literature | |
13. | ALA804112 | F | Tested to reverse NPY induced inhibition of forskolin-stimulated cAMP in SK-N-MC cells is evaluated. | Homo sapiens | 1 | ALA1130762 | cell-based format | Scientific Literature | |
14. | ALA805669 | F | Compound was evaluated in a functional assay against SK-NM-C cells stably transfected with the human H3 receptor | Homo sapiens | 1 | ALA1145732 | cell-based format | Scientific Literature | |
15. | ALA910576 | F | Antiproliferative activity against human SK-N-MC cells after 96 hrs by MTT assay | Homo sapiens | 8 | ALA1137318 | cell-based format | Scientific Literature | |
16. | ALA890747 | F | Antiproliferative activity against human SK-N-MC cells after 72 hrs by MTT assay | Homo sapiens | 20 | ALA1146224 | cell-based format | Scientific Literature | |
17. | ALA890749 | F | Effect on iron release in SK-N-MC cells | Homo sapiens | 3 | ALA1146224 | cell-based format | Scientific Literature | |
18. | ALA890750 | F | Inhibition of iron uptake from transferrin in SK-N-MC cells at 50 uM relative to control | Homo sapiens | 5 | ALA1146224 | cell-based format | Scientific Literature | |
19. | ALA891360 | F | Antiproliferative activity against human SK-N-MC cells by MTT assay | Homo sapiens | 13 | ALA1146320 | cell-based format | Scientific Literature | |
20. | ALA901744 | F | Antiproliferative activity against human SK-N-MC cells by MTT assay | Homo sapiens | 14 | ALA1138273 | cell-based format | Scientific Literature |